Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents

Molecular Psychiatry volume 5, pages 514–522 (2000)Cite this article

Abstract

Cumulative data suggest depression in adulthood being connected to reduced availability of brain serotonin while the role of dopamine remains less specific. Prospective studies have shown a continuity of depressive episodes from childhood to adulthood, combined with poor social function and excess mortality. The object of this study was to examine whether alterations in brain serotonin and/or dopamine transporter levels are already present in depressive children and adolescents. We examined 41 drug-naive patients (aged 7–17) by single photon emission tomography (SPET) using iodine-123-labelled 2β-carbomethoxy-3β(iodophenyl) tropane [123I]β-CIT as a tracer for monoamine transporters. In addition to the ordinary clinical examination, the patients were given a structured interview and information was gathered from teachers and parents with questionnaires. The diagnoses were established by consensus evaluation between three child psychiatrists. To test the serotonin hypothesis and the dopamine hypothesis regarding depression in children and adolescents, the series was divided into groups with depression present (31) and no depression present (10). In this study, the depressive child and adolescent patients had significantly higher serotonin transporter availability (P < 0.02) in the hypothalamic/midbrain area. age did not correlate to the hypothalamic/midbrain serotonin transporter binding ratio. no significant difference in dopamine transporter availability in striatum was found between the depressive and the non-depressive children and adolescents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Harkavy-Friedman JM et al. Monoamines and behaviour, a multi-aminergic perspective Br J Psychiatry 1990; 157: 723–734

    Article  CAS  Google Scholar 

  2. Wickelgren I . Getting brain's attention Science 1991; 271: 35–37

    Google Scholar 

  3. Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL et al. Imaging D2 receptor occupancy by endogenous dopamine in humans Neuropsychopharmacology 1997; 17: 162–174

    Article  CAS  Google Scholar 

  4. Uhl GR . Neurotransmitter transporter (plus). A promising new gene family Trends Neurosci 1992; 15: 265–268

    Article  CAS  Google Scholar 

  5. Charney DS, Menkes DB, Phil M, Heninger G . Receptor sensitivity and the mechanism of action of antidepressant treatment Arch Gen Psychiatry 1981; 38: 1160–1180

    Article  CAS  Google Scholar 

  6. Viinamäki H, Kuokka J, Tiihonen J, Lehtonen J . Change in monoamine transporter density related to clinical recovery: a case-control study Nord J Psychiatry 1998; 52: 39–44

    Article  Google Scholar 

  7. Lesh K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996; 274: 1527–1531

    Article  Google Scholar 

  8. Ogilve AD, Battersby S, Bubb VJ, Fink G, Harmar JA, Goodwin GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression Lancet 1996; 347: 731–733

    Article  Google Scholar 

  9. Collier DA, Stoeber G, Li T, Heils A, Catalan M, DiBella D . A promoter of the serotonin gene: possible role in the susceptibility to affective disorder Mol Psychiatry 1996; 1: 453–460

    CAS  Google Scholar 

  10. Bergström KA, Kuikka JT, Ahonen A, Vanninen EI . 123-β-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans J Nucl Biol Med 1993; 38:: (suppl 1 to no 4) 128–131

    Google Scholar 

  11. Tiihonen J, Kuikka JT, Bergström KA, Karhu J, Viinamäki H, Lehtonen J et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behavior Eur J Nucl Med 1997; 24: 1253–1260

    Article  CAS  Google Scholar 

  12. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB et al. Reduced central serotonin transporters in alcoholism Am J Psychiatry 1998; 155: 1544–1549

    Article  CAS  Google Scholar 

  13. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography Biol Psychiatry 1998; 44: 1090–1098

    Article  CAS  Google Scholar 

  14. Harrington R, Fudge H, Rutter M, Picles A, Hill J . Adult outcomes of childhood and adolescent depression I Arch Gen Psychiatry 1990; 47: 465–473

    Article  CAS  Google Scholar 

  15. Drevets WC, Price JL, Todd JL, Reich T, Vannier M, Raichle ME . Subgenual prefrontal cortex abnormalities in mood disorders Nature 1997; 386: 824–827

    Article  CAS  Google Scholar 

  16. Bucholz KK, Cloninger CR, Dinwiddle SH, Hesselbrock VM, Nurberger JI, Reich T et al. A new, semi structured psychiatric interview for use in genetic linkage studies: a report of the reliability of the SSAGA J Stud Alcohol 1994; 55: 149–158

    Article  CAS  Google Scholar 

  17. Achenbach TM, Edelbrock CS . Manual for the child behavior checklist and revised child behavior profile University Associates in Psychiatry: Burlington, VT 1983

    Google Scholar 

  18. Kovacs M . Rating scales to assess depression in school-aged children Acta Paedopsych 1981; 46: 305–315

    CAS  Google Scholar 

  19. Hiltunen J, Åkerman KK, Kuikka JT, Bergström KA, Halldin C, Nikula T et al. Iodine-123 labeled nor-β-CIT as potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography Eur J Nucl Med 1998; 25: 19–23

    Article  CAS  Google Scholar 

  20. Ahonen A, Dahlström M, Moilanen I, Torniainen P, Heikkilä J . Brain serotonin transporters in depressive children. In: Bergman H, Köhn H, Sinzinger H (eds) Radioactive Isotopes in Clinical Medicine and Research Birkhauser Verlag: Basel/Switzerland 1999; 31–36

    Chapter  Google Scholar 

  21. Staley JK, Basile M, Flynn DD, Mash DC . Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization J Neurochem 1994; 62: 549–556

    Article  CAS  Google Scholar 

  22. Laine TPJ, Ahonen A, Torniainen P, Heikkilä J, Pyhtinen J, Räsänen P et al. Dopamine transporters increase in human brain after alcohol withdrawal Mol Psychiatry 1999; 4: 189–191, 104–105

    Google Scholar 

  23. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G et al. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo J Neural Transm Gen Sect 1995; 100: 247–256

    Article  CAS  Google Scholar 

  24. Fujita M, Takatoku K, Matoba Y, Nishiura M, Kobayashi K, Inoue O et al. Differential kinetics of [123I]-β-CIT binding to dopamine and serotonin transporters Eur J Nucl Med 1996; 23: 431–436

    Article  CAS  Google Scholar 

  25. Brucke T, Kornhuber J, Angelberger P, Asenbaum S, Frassine H, Podreka I . SPECT imaging of dopamine and serotonin transporters with [123C]β-CIT. Binding kinetics in human brain J Neural Transm Gen Sect 1993; 94: 137–146

    Article  CAS  Google Scholar 

  26. Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M et al. Imaging serotonin and dopamine transporters with [123I]β-CIT SPECT: binding kinetics and effects of normal aging J Nucl Med 2000; 41: 36–44

    CAS  PubMed  Google Scholar 

  27. Träskman L, Åsberg M, Bertilsson L, Sjöstrand L . Monoamine metabolites in CSF and suicidal behavior Arch Gen Psychiatry 1981; 38: 631–636

    Article  Google Scholar 

  28. Mann JJ, McBride A, Anderson GM, Miezkowski TA . Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology Biol Psychiatry 1992; 32: 243–257

    Article  CAS  Google Scholar 

  29. Quintana J . Platelet serotonin and plasma tryptophan decreases in endogenous depression: clinical, therapeutic and biological correlations J Affect Disord 1992; 24: 55–62

    Article  CAS  Google Scholar 

  30. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S . Plasma prolactin changes following fenflurame in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression Life Sci 1984; 34: 1029–1039

    Article  CAS  Google Scholar 

  31. Price LH, Charney DS, Delgado PL, Heninger GR . Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy controls Arch Gen Psychiatry 1991; 148: 1518–1526

    CAS  Google Scholar 

  32. Leake A, Fairbairn AF, McKeith IG, Ferrier N . Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates Psychiatry Res 1991; 39: 155–165

    Article  CAS  Google Scholar 

  33. Stanley M, Virgilio J, Gershon S . Tritiated imipramine binding sites are decreased in the frontal cortex of suicide victims Science 1982; 216: 1337–1339

    Article  CAS  Google Scholar 

  34. Stanley M, Mann T . Increased serotonin-2 binding sites in frontal cortex of suicide victims Lancet 1983; 1: 214–216

    Article  CAS  Google Scholar 

  35. Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M . 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala Brain Res 1993; 614: 37–44

    Article  CAS  Google Scholar 

  36. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Raijkowska G . Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression—postmortem evidence for decreased serotonin activity J Neurosci 1998; 18: 7394–7401

    Article  CAS  Google Scholar 

  37. Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek B, Brown GM et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study Am J Psychiatry 1999; 156: 1029–1034

    CAS  PubMed  Google Scholar 

  38. Anderson IM, Tomenson BM . The efficiency of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants J Psychopharmacology 1994; 8: 238–249

    Article  CAS  Google Scholar 

  39. Emslie GJ, Rush JA, Weinberg WA, Kowatch RA, Hughes CW, Carmody T et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression Arch Gen Psychiatry 1997; 54: 1031–1037

    Article  CAS  Google Scholar 

  40. Ryan ND, Birmaher B, Perel JM, Dahl RE, Meyer V, Al-Shabbout M et al. Neuroendocrine response to L-5-hydroxytryptophane challenge in prepubertal major depression: depressed vs normal children Arch Gen Psychiatry 1992; 49: 843–851

    Article  CAS  Google Scholar 

  41. Birmaher B, Kaufman J, Brent DA, Dahl RE, Perel JM, Al-Shabbout M et al. Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder Arch Gen Psychiatry 1997; 54: 1113–1119

    Article  CAS  Google Scholar 

  42. Shoulz W, Dayan P, Montague PR . A neural substrate of prediction and reward Science 1997; 275: 1593

    Article  Google Scholar 

  43. Volkov ND, Wang G-J, Fishman MW, Foltin RW, Fowler JS, Abumrad NN et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy Nature 1997; 386: 827

    Article  Google Scholar 

  44. Wolfe N, Katz DI, Albert ML et al. Neuropsychological profile linked to low dopamine in Alzheimer's disease, major depression and Parkinson's disease J Neurol Neurosurg Psychiatry 1990; 53: 915–917

    Article  CAS  Google Scholar 

  45. Willner P . The mesolimbic dopamine system as target for rapid antidepressant action Int Clin Psychopharmacol 1997; 12: (suppl 3) S7–S14

    Article  Google Scholar 

  46. Kapur S, Mann JJ . Role of dopaminergic system in depression Biol Psychiatry 1992; 32: 1–17

    Article  CAS  Google Scholar 

  47. Laine PJ, Ahonen A, Räsänen P, Tiihonen J . Dopamine transporter availability and depressive symptoms during alcohol withdrawal Psychiatry Res 1999; 90: 153–157

    Article  CAS  Google Scholar 

  48. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG . Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 1999; 283: 397–401

    Article  CAS  Google Scholar 

  49. Laruelle M, Baldwin RM, Malison RT, Zea-Ponse Y, Zoghbi SS, Al-Tikriti MS et al. SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT: pharmacological characterization of brain uptake in non-human primates Synapse 1993; 13: 295–309

    Article  CAS  Google Scholar 

  50. Farde L, Halldin C, Muller L, Suhari T, Karlsson P, Hall H . PET-study of [123C]β-CIT binding to monoamine transporters in the monkey and human brain Synapse 1994; 16: 93–103

    Article  CAS  Google Scholar 

  51. Little K, Kirkman J, Carrol F, Breese G, Duncan G . [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in human brain J Neurochem 1993; 61: 1996–2006

    Article  CAS  Google Scholar 

  52. Baker SC, Frith CD, Dolan RJ . The interaction between mood and cognitive function studied with PET Psychol Med 1997; 27: 565–578

    Article  CAS  Google Scholar 

  53. Gunther I, Hall H, Halldin C, Swahn CG, Farde L, Sedvall G . [123I]-β-CIT-FE and [123I]-β-CIT-FP are superior to [123I]-β-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain Nucl Med Biol 1997; 24: 629–634

    Article  CAS  Google Scholar 

  54. Fisher RE, Morris ED, Alpert NM, Fishman AJ . In vivo imaging of neuromodulatory synaptic transmission using PET: a review of relevant neurophysiology Human Brain Mapp 1995; 3: 24–34

    Article  Google Scholar 

  55. Papechi R, McClure D . Homovanillinic and 5-hydroxyindoleacetatic acid in cerebrospinal fluid in depressed patients Arch Gen Psychiatry 1971; 25: 354–358

    Article  Google Scholar 

  56. Bremner JD, Innis RB, Salomon RM, Staib LH, Chin K, Miller HL et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse Arch Gen Psychiatry 1997; 54: 364–374

    Article  CAS  Google Scholar 

  57. Heinz A, Jones DW, Weinberger DR, Hommer D . Serotonin transporter availability in alcoholics and non-human primates – [I-123]β-CIT studies Eur J Nucl Med 1999; 26: 972

    Google Scholar 

  58. Heinz A, Higley JD, Gorey JG, Saunders RC, Jones DW, Hommer D et al. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in non-human primates Am J Psychiatry 1998; 155: 1023–1028

    Article  CAS  Google Scholar 

  59. Angold A, Costello EJ . Depressive comorbidity in children and adolescents: empirical, theoretical and methodological issues Am J Psychiatry 1993; 150: 1779–1791

    Article  CAS  Google Scholar 

  60. Anthony BJ . Cognitive development in adolescence. In: Noshpitz JD, Flaverty LT (eds) Handbook of Child and Adolescent Psychiatry John Wiley: New York 1997; 65–78

    Google Scholar 

  61. Pine DS, Cohen E, Cohen P, Brook J . Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? Am J Psychiatry 1999; 156: 133–135

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Clinic of Child Psychiatry, University of Oulu, Oulu, 90220, Finland

    M Dahlström, H Ebeling & I Moilanen

  2. Department of Clinical Chemistry, Division of Nuclear Medicine, University of Oulu, Oulu, 90 220, Finland

    A Ahonen, P Torniainen & J Heikkilä

  3. Department of Clinical Physiology and Nuclear Medicine, Helsinki University Central Hospital, Finland

    A Ahonen

Authors
  1. M Dahlström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Ahonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Ebeling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Torniainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Heikkilä
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I Moilanen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Dahlström.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dahlström, M., Ahonen, A., Ebeling, H. et al. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. Mol Psychiatry 5, 514–522 (2000). https://doi.org/10.1038/sj.mp.4000766

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000766

Keywords

This article is cited by

Search

Advanced search

Quick links